{
    "code": "01027027",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01027027",
    "time": "2024-04-11 19:11:24",
    "許可證字號": "衛署藥製字第027027號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/04\/08",
    "發證\/登錄日期": "72\/04\/08",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00102702704",
    "中文品名": "利通膠囊",
    "英文品名": "SINULIN CAPSULES",
    "適應症": "過敏性鼻炎，枯草熱所引起之相關症狀(鼻塞、流鼻水、打噴嚏、眼睛及喉部搔癢)。",
    "劑型": "130膠囊劑",
    "包裝": "6~21粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "17醫師藥師藥劑生指示藥品",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CARBINOXAMINE MALEATE, PSEUDOEPHEDRINE HCL, CAFFEINE ANHYDROUS, LYSOZYME (CHLORIDE), GLYCYRRHIZINIC ACID (EQ TO GLYCYRRHETINIC ACID GLYCOSIDE)(EQ TO GLYCYRRHIZIC ACID )",
    "限制項目": "01國　產",
    "申請商名稱": "臺灣汎生製藥廠股份有限公司",
    "申請商地址": "高雄市鳥松區坔埔里大同路5-1號及神農路330號",
    "主製造廠": [
        {
            "製造廠名稱": "臺灣汎生製藥廠股份有限公司",
            "製造廠廠址": "高雄市鳥松區？埔村大同路５號之１",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099101 抗過敏抗組織胺用藥Drugs for antihypersensitivity and antihistamine",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0400000610",
            "成分名稱": "CARBINOXAMINE MALEATE",
            "含量描述": "",
            "含量": "4.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1212002610",
            "成分名稱": "PSEUDOEPHEDRINE HCL",
            "含量描述": "",
            "含量": "60.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2820000450",
            "成分名稱": "CAFFEINE ANHYDROUS",
            "含量描述": "",
            "含量": "40.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4400091310",
            "成分名稱": "LYSOZYME (CHLORIDE)",
            "含量描述": "",
            "含量": "12.5000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9200004600",
            "成分名稱": "GLYCYRRHIZINIC ACID (EQ TO GLYCYRRHETINIC ACID GLYCOSIDE)(EQ TO GLYCYRRHIZIC ACID )",
            "含量描述": "",
            "含量": "15.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "鮮紅\/白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "長圓柱形",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "利通膠囊外觀-104-12-19(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027027&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "利通膠囊_仿單-107-06-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027027&Seq=003&Type=9"
        },
        {
            "title": "利通膠囊_鋁箔-107-06-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027027&Seq=006&Type=8"
        },
        {
            "title": "利通膠囊_外盒-107-06-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027027&Seq=005&Type=8"
        },
        {
            "title": "利通膠囊_標籤-107-06-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01027027&Seq=004&Type=8"
        }
    ]
}